About Femasys Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.femasys.com/
Frequently Asked Questions
What is the 52-week range for FEMY?
The 52-week high is $22.2 and the 52-week low is $1.96.
What is the P/E ratio for FEMY?
The P/E ratio data is currently unavailable.
What is the dividend yield for FEMY?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -216.46%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -511.77%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.84.
Analyst Recommendation Trends
Wall Street analyst consensus for FEMY over the last few months:
Latest FEMY News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
-- Leading multi-site OB/GYN health practice to implement FemVue® for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announced today that Minnesota Women’s Care w
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centersATLANTA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announced today a partnership with CapexMD
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-07 | Mifek Jeffrey Gerald | +3,125 | - | - |
| 2026-08-07 | Mifek Jeffrey Gerald | +3,125 | - | - |
| 2026-08-07 | Mifek Jeffrey Gerald | +3,125 | $3.2 | $10,000 |
| 2026-08-07 | Sipos Jeremy Alexander | +3,125 | - | - |
| 2026-08-07 | Sipos Jeremy Alexander | +3,125 | - | - |
| 2026-08-07 | Sipos Jeremy Alexander | +3,125 | $3.2 | $10,000 |
| 2026-08-07 | Canning John Charles | +4,375 | - | - |
| 2026-08-07 | Canning John Charles | +4,375 | - | - |
| 2026-08-07 | Canning John Charles | +4,375 | $3.2 | $14,000 |
| 2026-08-07 | Lee-Sepsick Kathy | +15,625 | - | - |
| 2026-08-07 | Lee-Sepsick Kathy | +15,625 | - | - |
| 2026-08-07 | Lee-Sepsick Kathy | +15,625 | $3.2 | $50,000 |
| 2026-08-07 | Elefant Dov | +15,625 | - | - |
| 2026-08-07 | Elefant Dov | +15,625 | - | - |
| 2026-08-07 | Elefant Dov | +15,625 | $3.2 | $50,000 |
| 2026-07-06 | Mifek Jeffrey Gerald | +6,250 | - | - |
| 2026-06-24 | Eichenbaum Kenneth D. | +880 | - | - |
| 2026-06-24 | Uzialko Edward R | +880 | - | - |
| 2026-06-24 | Milnes Alistair | +880 | - | - |
| 2026-06-24 | Larsen Charles | +880 | - | - |
| 2026-03-30 | Canning John Charles | +150,000 | - | - |
| 2026-03-19 | Eichenbaum Kenneth D. | +102,366 | - | - |
| 2026-03-19 | Lee-Sepsick Kathy | +68,244 | - | - |
| 2026-03-19 | Larsen Charles | +34,122 | - | - |
| 2026-03-19 | Elefant Dov | +34,122 | - | - |
| 2026-03-18 | Eichenbaum Kenneth D. | +35,200 | - | - |
| 2026-02-19 | Lee-Sepsick Kathy | +282,000 | - | - |
| 2026-02-19 | Lee-Sepsick Kathy | +447,000 | - | - |
| 2026-02-19 | Elefant Dov | +169,000 | - | - |
| 2026-02-19 | Elefant Dov | +173,000 | - | - |
| 2026-02-02 | Sipos Jeremy Alexander | +80,000 | - | - |
| 2025-11-07 | Lee-Sepsick Kathy | +68,244 | - | - |
| 2025-11-07 | Lee-Sepsick Kathy | +68,244 | - | - |
| 2025-11-07 | Lee-Sepsick Kathy | +68,244 | - | - |
| 2025-11-07 | Lee-Sepsick Kathy | 0 | - | - |
| 2025-11-07 | Larsen Charles | +34,122 | - | - |
| 2025-11-07 | Larsen Charles | +34,122 | - | - |
| 2025-11-07 | Larsen Charles | +34,122 | - | - |
| 2025-11-07 | Larsen Charles | 0 | - | - |
| 2025-11-07 | Elefant Dov | +34,122 | - | - |
| 2025-11-07 | Elefant Dov | +34,122 | - | - |
| 2025-11-07 | Elefant Dov | +34,122 | - | - |
| 2025-11-07 | Elefant Dov | 0 | - | - |